Found 48 matching trials
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). PHASE3 This study is a Phase 3 global, multicenter, placebo-controlled double-blin...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma PHASE2 This phase II trial tests how well a combination of three immunotherapy dru...
Show More Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas PHASE1 This phase I/II trial tests the safety, side effects best dose and effect o...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer PHASE3 The purpose of this study is to assess the efficacy and safety of platinum-...
Show More Location
Pacific Cancer Medical Center
Learn More & Join Trial
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma PHASE2 This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105) PHASE1 The purpose of this study is to assess the safety and tolerability and to d...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Study of SV-BR-1-GM With Retifanlimab PHASE1 This is an open-label, phase I/II double arm study of the SV-BR-1-GM regime...
Show More Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial
INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) PHASE3 The purpose of this study is to assess the efficacy and safety of INCMGA000...
Show More Location
Multiple Locations
Learn More & Join Trial
An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC) N/A To provide retifanlimab, on a reactive basis, to adult patients with squamo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) PHASE2 The purpose of this study is to assess the efficacy of INCMGA00012 in parti...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial